AOD-9604 Test Report: Analytical Purity, Mass Spectrometry, and Quality Verification

At a glance: Interpreting an AOD-9604 test report

A rigorous AOD-9604 test report verifies three essential parameters: chemical identity, chromatographic purity, and microbiological safety. The baseline standard for high-tier in vitro research requires an analytical purity of ≥98.0% determined via high-performance liquid chromatography (RP-HPLC). Mass spectrometry must confirm the exact molecular weight matching the synthesized peptide sequence (Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe with a C-terminal tyrosine addition), and bacterial endotoxin levels must fall safely below <0.05 EU/mg.

When auditing analytical documentation for prospective reagents, research managers should ensure every Certificate of Analysis (COA) includes raw chromatograms, explicit calibration details, and a lot number that matches the physical vial label exactly. Standardized testing guarantees reproducible experimental conditions across cell line cultures, enzyme assays, and metabolic binding models.

PX1 Research publishes unedited, lot-specific third-party laboratory reports for every production batch. Principal investigators can inspect chromatograms and verify chemical specifications directly before place-of-order execution, ensuring total experimental integrity.

What is AOD-9604 and how is analytical purity evaluated?

AOD-9604 is a synthetic hexadecapeptide peptide derivative derived from the C-terminal region of human growth hormone (hGH, residues 177–191) with an additional N-terminal tyrosine residue added to stabilize the peptide structure. Designed specifically to isolate specific lipolytic domains without triggering systemic somatogenic signaling, the compound features a critical intramolecular disulfide bridge between Cys7 and Cys14 that dictates its tertiary conformation and receptor binding dynamics.

Evaluating the purity of AOD-9604 requires sensitive analytical separation techniques because improperly folded sequence isomers, truncated deletion sequences, or oxidized sulfur species can skew laboratory measurements. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) utilizing C18 hydrophobic stationary phases and acetonitrile/water gradients containing trifluoroacetic acid (TFA) provides the primary quantitative assay for chromatographic purity.

To review verified material conforming to strict analytical criteria, researchers can examine our live inventory when they order 5 mg vials of AOD-9604 or browse our complete selection of research peptides.

Key components of an authentic AOD-9604 test report

A legitimate, peer-review-grade AOD-9604 test report goes far beyond a simple text-based summary of purity percentages. A complete verification package comprises three distinct analytical testing modules executed by an independent ISO/IEC 17025-accredited laboratory:

1. Reverse-Phase HPLC (RP-HPLC) Chromatogram: The chromatogram displays the elution profile of the sample as ultraviolet (UV) absorbance measured at 214 nm or 220 nm (peptide backbone absorbances). The main sharp peak represents intact AOD-9604, while residual background noise or minor secondary peaks represent impurities. Standard specifications require a relative peak area integrating to ≥98.0% (and frequently >99.0% for PX1 Research lots).

2. Electrospray Ionization Mass Spectrometry (ESI-MS): Mass spectrometry measures the mass-to-charge ratio (m/z) of the ionized compound to confirm structural identity. AOD-9604 possesses a theoretical molecular weight of approximately 1815.1 Da. The ESI-MS spectrum must exhibit accurate charge-state signals (such as [M+H]+, [M+2H]2+, or [M+3H]3+) that resolve to the exact theoretical mass, ruling out sequence mutations or incorrect amino acid substitutions.

3. Bacterial Endotoxin Testing (LAL Assay): Essential for cellular assays and in vitro biological models sensitive to lipopolysaccharide contamination, Endotoxin Testing via the Limulus Amebocyte Lysate (LAL) chromogenic method confirms bacterial contamination levels. Certified lots must contain <0.01 to <0.05 Endotoxin Units per milligram (EU/mg).

Benchmarking criteria: PX1 Research vs. industry standards

Selecting a supplier for reference-standard peptides requires establishing uncompromising evaluation criteria. Below is the standard protocol PX1 Research applies to every lot of AOD-9604 compared against typical market vendors:

• Purity Verification: Standard vendors often rely on internal UV-Vis estimates or static supplier batch sheets. PX1 Research enforces mandatory independent third-party RP-HPLC analysis on every lot, establishing a strict baseline purity standard of ≥99.0%.

• Molecular Weight Identification: Generic vendors frequently omit raw mass spectrometry spectra. PX1 Research includes high-resolution ESI-MS spectra confirming exact molecular weight (1815.1 Da) for every batch.

• Biological Contaminant Screening: Standard suppliers rarely provide endotoxin data or test only upon special request. PX1 Research conducts mandatory LAL endotoxin testing per lot, confirming levels well under <0.05 EU/mg.

• Domestic Manufacturing & Traceability: Overseas vendors utilize broad, untraceable master lot numbers. PX1 Research utilizes 100% US-based peptide synthesis with distinct, scan-verifiable lot codes printed directly on every vial tag.

• Storage & Transit Control: Unregulated suppliers ship lyophilized peptides at ambient temperatures without climate-controlled storage preceding dispatch. PX1 Research stores material under regulated sub-zero conditions and dispatches via temperature-stable domestic shipping nodes.

To explore our complete quality assurance framework and technical whitepapers, visit the PX1 Research learning portal.

Red flags to look for in vendor peptide COAs and test reports

Procurement officers and laboratory researchers must remain vigilant against fraudulent or misrepresentative testing documentation circulating within the research reagent sector. The presence of any of the following red flags indicates elevated risk to experimental reproducibility:

• Photoreactivity or Crop Mark Manipulation: PDF test reports that lack raw axis labels (retention time in minutes on the X-axis, milli-Absorbance Units [mAU] on the Y-axis) or show visible clipping around peak resolution windows indicate potential document alteration.

• Static or Reused Chromatograms: Comparing COAs across multiple distinct batch numbers should reveal slight, normal variance in retention times (e.g., 12.14 min vs 12.18 min). Identical chromatograms across different lot numbers signal copied documentation.

• Absence of Mass Spectrometry: HPLC alone confirms that a molecule is homogeneous, but it cannot confirm that the molecule is actually AOD-9604. Without ESI-MS mass verification, a supplier cannot prove the peak is not a random sequence isomer or scrambled peptide fragment.

• Missing Laboratory Verification Seal: Authentic third-party reports state the name, ISO accreditation number, physical address, and signatory contact of the testing facility, allowing researchers to call the laboratory directly and verify authenticity.

Reconstitution, solubility, and handling protocols for AOD-9604 in vitro research

In vitro testing requires precise reconstitution technique to preserve structural integrity, maintain complete solubility, and avoid micro-precipitation of the disulfide-bonded peptide chain.

1. Reconstitution Medium: Lyophilized AOD-9604 displays optimal solubility when dissolved in sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile standard Phosphate-Buffered Saline (PBS, pH 7.4). For sensitive enzymatic cell assays where benzyl alcohol is contraindicated, sterile Deionized Sterile Water for Injection (wfi) should be used.

2. Physical Handling: Slowly introduce the liquid reconstituting agent down the interior glass wall of the vial rather than directing the jet stream directly onto the lyophilized cake. Gently swirl the vial until complete dissolution occurs. Never subject reconstituted peptide solutions to vigorous vortexing or mechanical shaking, which can cause mechanical shear stress and denature the disulfide bond.

3. Thermal Storage Limits: Unreconstituted lyophilized vials must be kept stored at -20°C for long-term stability (up to 24 months). Once reconstituted into aqueous solution, aliquots should be refrigerated at 2°C to 8°C and evaluated within 28 days, or frozen once at -80°C to avoid repeated freeze-thaw cycles.

Comparing AOD-9604 with related research compounds

To properly categorize metabolic and peptide fragment mechanisms in preclinical models, researchers often run parallel comparative studies evaluating related somatotrophic and growth hormone-releasing factors:

• Fragment 176-191 Guide: While AOD-9604 is an modified N-terminal tyrosine derivative of hGH 177-191, un-modified Fragment 176-191 represents the unmodified 16-amino-acid C-terminus. Research compares structural stability and terminal degradation between both analogs.

• CJC-1295 Guide: A synthetic GHRH analog studied for its affinity to pituitary GHRH receptors, serving as an upstream biological comparison to direct hGH fragment analogs.

• Ipamorelin Guide: A selective ghrelin secretagogue receptor agonist used in comparative cellular models evaluating pulse-frequency somatotroph stimulation versus isolated fragment lipolytic pathway signaling.

• Tesamorelin Guide: A stabilized GHRH peptide featuring a trans-3-hexenoic acid group, frequently audited in metabolic research side-by-side with smaller hGH domains like AOD-9604.

Laboratories conducting broad structural assays can view our full catalog of high-purity materials on our all peptides directory or register for high-volume supply through our wholesale peptide procurement division.

Methodology of analytical testing for sequence verification

To achieve peak confidence in analytical validation, PX1 Research contracts testing facilities that employ state-of-the-art analytical chemistry instrumentation. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) relies on an analytical C18 column (typically 4.6 mm × 250 mm, 5 µm particle size) operated at a controlled column temperature of 40°C.

Elution is accomplished using a linear binary gradient. Mobile Phase A consists of 0.1% trifluoroacetic acid (TFA) in HPLC-grade water, while Mobile Phase B consists of 0.1% TFA in acetonitrile (ACN). As the proportion of Mobile Phase B increases over a typical 30-minute run, AOD-9604 elutes at a distinct retention time, separated from hydrophobic background impurities and hydrophilic peptide fragments.

Simultaneously, Mass Spectrometry utilizing Electrospray Ionization (ESI-TOF or quadrupole mass analyzers) introduces the isolated sample into a high-vacuum mass analyzer. Ionized signals yield crisp m/z spectral peaks matching the theoretical molecular formula C78H123N23O23S2, confirming that the synthesized material is 100% molecularly correct.

Ordering AOD-9604 from PX1 Research

When your laboratory requires analytical-grade peptides with full lot traceability and transparent third-party testing reports, PX1 Research provides seamless procurement. Every shipment includes certified vials, detailed batch documentation access, and tamper-evident packaging to ensure sample preservation upon arrival.

Key fulfillment specifications include:

• Standard Packaging: Available in high-purity lyophilized 5 mg glass vials sealed under inert nitrogen atmosphere.

• Dispatch Timelines: Same-day dispatch for all orders placed before 3:00 PM EST, Monday through Friday.

• Domestic Logistics: Fast, fully tracked domestic shipping originating from our dual fulfillment centers in California and Arizona.

• Documentation Access: Immediate QR code and direct web access to lot-specific HPLC/MS and endotoxin test reports.

• Research Support: Dedicated technical response team available to answer analytical and bulk procurement inquiries within 2 hours during normal business hours.

Secure your batch of high-purity material today: order AOD-9604 vials directly from PX1 Research.